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The equine herpesvirus 1 immediate-early (IE) phosphoprotein is essential for the activation of transcription from viral early
and late promoters and trans-represses its own promoter. Transient-transfection assays showed that the IE protein
trans-represses the g2 late gK promoter. Gel shift and DNase I footprinting assays demonstrated that the IE protein binds
to the gK promoter sequences from 242 to 226 and from 213 to 112 that overlap the transcription initiation site (11). These
results indicated that the IE protein binds to the transcription initiation site of the gK promoter sequences, thereby repressing
transcription. On the other hand, the EICP0 protein trans-activates the g2 late gK promoter [Bowles, D. E., Holden, V. R., Zhao,
Y., and O’Callaghan, D. J. (1997). The ICP0 protein of equine herpesvirus 1 is an early protein that independently transactivates
expression of all classes of viral promoters. J. Virol. 71, 4904–4914]. Overall, the EICP0 protein is able to release the gK
promoter from the repressive effects of the IE protein. It has not been previously demonstrated that the major immediate-
early transcriptional regulator of a herpesvirus represses expression of a late gene during infection. © 1999 Academic Press
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tEquine herpesvirus type 1 (EHV-1), an Alphaherpesviri-
ae member, is a major pathogen of equines, causing
espiratory disease, neurological disorders, and sponta-
eous abortions in pregnant mares (1, 17). During a
roductive lytic infection, the genes of EHV-1 are coor-
inately expressed and temporally regulated in immedi-
te-early (IE), early (E), and late (L) fashion (3, 8). The
egulation of this cascade of gene expression is gov-
rned by the action of at least five characterized EHV-1
egulatory proteins: the IE protein (9, 13, 14, 20–22), the
ICP0 protein (2), the EICP22 protein (11, 12), the EICP27
rotein (23, 24), and the E-TIF (a-TIF homolog) protein (6,
5, 19).
The glycoprotein K (gK) gene of equine herpesvirus
ype 1 is predicted to encode a 343-amino acid (aa)
rotein that exhibits significant homology to gK of HSV-1
nd has characteristics of a glycoprotein, such as (i) a
otential N-terminal signal sequence, (ii) two potential
ites for N-linked glycosylation, and (iii) four transmem-
rane domains (23). The gK promoter is a true late (g2)
romoter because synthesis of the gK transcript is de-
endent on prior DNA replication (23).
The IE gene (IR1) of EHV-1 is essential for replication
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Microbiology and Immunology, Louisiana
tate University Medical Center, 1501 Kings Highway, P.O. Box 33932,
hreveport, LA 71130-3932. Fax: (318) 675-5764. E-mail: DOCALL@cSUMC.EDU.
1737) and lies within each of the two inverted repeats and
ncodes a 1487-aa polypeptide (IE) (9). Transient-trans-
ection experiments have demonstrated that the IE gene
roduct trans-activates EHV-1 and heterologous viral
romoters, trans-represses its own expression, and acts
ynergistically with the EICP22 and EICP27 proteins to
rans-activate E and L promoters (12, 20, 24). Residues
22 to 597 (region 2 domain) of the IE protein are suffi-
ient for its sequence-specific DNA binding to the nucle-
tides positioned at 211 to 114 relative to the transcrip-
ion initiation site (11), which overlap the transcription
nitiation site in the EHV-1 IE gene (13). The IE protein
lso binds weakly to sequences in the E and L promoters
hat contain a degenerate version of the consensus bind-
ng sequence 59-ATCGT-39 (13). A potent transcriptional
ctivation domain lies within the first 89-aa residues of
he IE protein (21), and aa 963 to 970 are necessary for
uclear localization of truncated IE polypeptides (22).
In this paper, we report that the IE protein binds to the
ranscription initiation site of the gK promoter se-
uences, thereby repressing transcription, and the
ICP0 protein is able to release the gK promoter from the
epressive effects of the IE protein.
The IE Protein trans-Represses the gK Promoter. To
etermine whether the IE protein trans-activates the g2
ate gK promoter, transient-transfection assays were per-
ormed. When the pgK-CAT reporter plasmid was co-
ransfected with the IE expression vector pSVIE into L-M
ells, interestingly, a 5-fold decrease in CAT activity was
0042-6822/99 $30.00
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174 RAPID COMMUNICATIONbserved (Fig. 1A, bar 2). To confirm this result, transient-
ransfection assays were performed with the mutant IE
rotein (IEK498E; Lys498 3 Glu498) expression vector
SVIEK498E that is not able to bind to DNA (14). When
gK-CAT was cotransfected with pSVIEK498E, a 0.17-fold
ecrease in CAT activity was observed (Fig. 1A, bar 3),
ndicating that the DNA binding domain of the IE protein
s necessary to down-regulate the gK promoter. Further-
ore, the reduction in the expression of pgK-CAT re-
ponded to cotransfection with pSVIE in a dose-depen-
ent fashion (Fig. 1B). These results indicated that the IE
rotein trans-repressed the gK promoter.
To confirm these results, two upstream deletion
onstructs of the gK promoter were generated and
sed for CAT assays (Fig. 1C). To construct the
gK(2153/114)-CAT vector, the EcoRI–XbaI fragment
f pUCL4R, which was generated by insertion of a
coRI linker into the BsaI-digested pUCL4 (12), was
loned into EcoRI–XbaI-digested pcDNAI/AMP (In-
itrogen) and was designated pcDNA-gK(2153/114).
FIG. 1. Effect of the IE protein on the gK promoter. (A) The DNA bind
-M cells seeded at 3 3 106 cells per tissue culture dish (60 mm) in Eag
y the liposome-mediated DNA transfection method 24 h later (12). The
lasmids were transfected in 0.3-pmol amounts. The total amount of D
urther 5 h, the cells were washed and refed with fresh medium; 60 h
escribed (20). Each transfection was performed in triplicate. Data
rans-represses the gK promoter. Two pmol of pgK-CAT chimeric plasm
mol) of pSVIE into L-M cells. pSVIE and pgK-CAT have been descr
umerals indicate distances from the transcription initiation site (11
ncoding the CAT protein is indicated by an open rectangle. (D) The
nitiation site. L-M cells were transfected with 2.0 pmol of pgK-CAT repor
f effector plasmid. The liposome-mediated DNA transfection and CAT
UC19 vector DNA. Each transfection was performed in triplicate. Dathe HindIII–XbaI fragment of pcDNA-gK(2153/114) aas cloned into HindIII–XbaI-digested pCAT-Basic
Promega), resulting in the pgK(2153/114)-CAT clone.
o construct the pgK(283/114)-CAT vector, the
au3AI-XbaI fragment of pUCL4 (12) was cloned into
amHI-XbaI-digested pcDNAI/AMP (Invitrogen) and
as designated pcDNA-gK(283/114). The HindIII–
baI fragment of pcDNA-gK(283/114) was cloned into
indIII–XbaI-digested pCAT-Basic (Promega), result-
ng in the pgK(283/114)-CAT clone. As seen in Fig.
D, the IE protein trans-repressed the gK promoter.
hen upstream sequences from 2524 to 2153 were
eleted, the CAT activity slightly decreased but the IE
rotein still trans-repressed the gK(2153/114) pro-
oter. When upstream sequences from 2524 to 283
ere deleted, the IE protein still trans-repressed the
K(283/114) promoter. Interestingly, a deletion from
524 to 283 resulted in a threefold increase in CAT
ctivity, indicating that this region may contain inhibi-
ory cis-acting sequences. These results indicated
hat the IE protein trans-represses the gK promoter by
main of the IE protein is necessary to trans-repress the gK promoter.
nimum essential medium with 5% fetal bovine serum were transfected
AT reporter plasmid was transfected in 2.0-pmol amounts. All effector
r transfection was adjusted to 9 mg by the addition of pUC19. After a
otal cell extracts were prepared and CAT activities were assayed as
verages; error bars show standard deviations. (B) The IE protein
cotransfected with different concentrations (0, 0.1, 0.2, 0.3, 0.4, and 0.6
eviously (12, 20). (C) Deletion constructs of the gK promoter region.
T box (nt 2199 to 2195) and AP1 site (nt 280 to 274). The region
ein trans-represses the gK promoter by acting near the transcription
mids [pgK-CAT, pgK(2153/114) and pgK(283/114)-CAT] and 0.3 pmol
were performed as described in B. Controls were cotransfected with
verages; error bars show standard deviations.ing do
le’s mi
pgK-C
NA pe
later t
are a
id was
ibed pr
). CCAA
IE prot
ter plas
assaysffecting an area near the transcription initiation site.
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175RAPID COMMUNICATIONThe IE Protein Binds to the gK Promoter Sequences
hat Overlap the Transcription Initiation Site (11). To
dentify whether the IE protein binds to the transcription
nitiation site of the gK promoter, gel shift assays were
erformed. In these assays, the IE protein bound weakly
o the gK(A) probe (Figs. 2A and 2B, lane 1). The forma-
ion of the GST-IE(291-634)-gK(A) DNA complex was
ompletely blocked by the addition of unlabeled excess
ompetitor IE1, which contains the EHV-1 IE DNA se-
uences from 213 to 115 (13) (Fig. 2B, lane 2), but was
ot competed by the nonspecific competitor OCT1 oligo-
ucleotide (Fig. 2B, lane 3). The GST-IE(291-634)-gK(A)
NA complex was further shifted by the addition of
E-specific monoclonal antibody A1.4 (4) (Fig. 2B, lane 4).
owever, the IE protein did not bind to the gK(B) probe
nt 2524 to 283) (Fig. 2B, lanes 5 to 7). These results
ndicated that the IE protein binds specifically to se-
uences within 283 to 114 of the gK cap site.
There are two possible IE protein binding sites (IEBS)
FIG. 2. The IE protein binds to the gK promoter sequences that over
K promoter. Designations for the two probes used in gel shift assays
eport (23). (B) Gel shift assays. The radiolabeled probes, gK(A) (positio
g (lanes 1 to 5), 23 (1 mg) (lane 6), 33 (1.5 mg) (lane 7) of GST-IE(29
ndicate shifted and supershifted bands (arrow a and arrow b, respecti
romoter. OCT1 oligonucleotide (Promega) was used as nonspecific co
he figure. The pentanucleotide region containing the mutated bas
GTCGAGCGCCAACGTGTCTATAAAATC-39. (D) Gel shift analysis of th
ligonucleotides were incubated with 600 (lanes 1 to 10), 100 (lane 11), o
escribed (13). The 28-bp oligonucleotide IE1 and the OCT1 oligonuclithin sequences located at 283 to 114 of the gK pro- poter. In the DNase I footprinting assay, nucleotides
pstream of the TATA box from 242 to 226 and an area
ear the transcription initiation site from 213 to 112
ere partially protected by the IE protein (data not
hown). The two IE protein binding sequences of the gK
romoter are 59-AaCGT-39 (IEBS w2) and 59-AgCGT-39
IEBS w1), which are degenerate versions of the consen-
us binding sequence 59-ATCGT-39 (see Figs. 2C and 3).
o determine the nucleotide sequences of the IE protein
inding site in the gK promoter, additional gel shift as-
ays were performed. In these assays, the GST-IE(291-
34) protein bound very weakly, both to the gK2 (250 to
23) oligonucleotide, which contains IEBS w2, and to
K1 (216 to 112) oligonucleotide, which contains IEBS
1 (Fig. 2D, lanes 1 and 6, respectively), compared to the
E1 oligonucleotide (Fig. 2D, lanes 11 and 12). The for-
ation of the GST-IE(291-634)-gK2 DNA complexes or
he GST-IE(291-634)-gK1 DNA complexes were com-
letely blocked by the addition of unlabeled excess com-
transcription initiation site (11). (A) Map of the restriction sites of the
dicated in the map. Numbering of the nucleotides is as in a previous
3 to 114) and gK(B) (positions 2524 to 283), were incubated with 500
under the standard conditions previously described (13). The arrows
he 28-bp oligonucleotide IE1 contains bp 213 to 115 of the EHV-1 IE
r. (C) The oligonucleotides used as probes are indicated at the top of
hown. gK1, 59-GGCGGTGGAAGCGTTTGTTGTCGACGTG-39; gK2, 59-
tein with wild-type and mutant oligonucleotide probes. Radiolabeled
g (lane 12) of GST-IE(291-634) under the standard conditions previously
were described in B.lap the
are in
ns 215
1-634)
vely). T
mpetito
e is s
e IE pro
r 300 netitor IE1 (Fig. 2D, lanes 2 and 7, respectively), but were
n
n
o
g
(
i
I
d
t
A
r
s
b
m
t
s
i
a
C
o
d
w
I
w
(
p
d
p
t
s
t
t
r
b
2
(
o
E
o
T
w
s
p
D
b
i
a
w
b
t
b
C erform
176 RAPID COMMUNICATIONot competed by the nonspecific competitor OCT1 oligo-
ucleotide (Fig. 2D, lanes 3 and 8, respectively). On the
ther hand, no complex was observed when the mutant
Km2 and gKm1 oligonucleotides were used as probes
Fig. 2D, lanes 4 and 9, respectively). These results
ndicated that the IE protein binds to the IEBS w1 and
EBS w2 of the gK promoter. Unexpectedly, the IE protein
id not bind strongly to the gKc1 and gKc2 oligonucleo-
ides, which contain the conserved pentanucleotide 59-
TCGT-39 (Fig. 2D, lanes 5 and 10, respectively). This
esult suggested that the distal part of the consensus
equence 59-ATCGT-39 also is important for specific
inding. In the case of the ICP4 protein, the ATCGTC
otif alone is not sufficient for DNA binding and both
he proximal (ATCGT) and distal parts of the ICP4 con-
ensus DNA binding site are important for specific bind-
ng (5, 16, 18).
To confirm whether the IE protein binds to the IEBS w1
nd IEBS w2, CAT assays were performed with the pgK-
AT constructs containing the consensus pentanucle-
tide 59-ATCGT-39 or a mutant of it. The IE protein still
own-regulated pgKm1-CAT and pgKm2-CAT, which
ere mutated in the pentanucleotide of one of the two
EBS, but did not down-regulate pgKm2m1-CAT, which
as mutated in the pentanucleotide of both of the IEBS
FIG. 3. CAT assays with the pgK-CAT constructs containing the conse
he nucleotide sequences containing the transcription initiation region
ox region are underlined. The pgK-CAT constructs containing the mut
AT assay results are summarized in the table. Each transfection was pFig. 3). The IE protein also down-regulated pgKc1-CAT, ggKc2-CAT, and pgKc2c1-CAT (Fig. 3). These results in-
icated that the IE protein down-regulates the g2 late gK
romoter by binding the IEBS w1 and/or the IEBS w2 of
he gK promoter. The EICP0 protein transactivated
trongly all of the pgK-CAT constructs (Fig. 3), indicating
hat all of the pgK-CAT constructs were functional. Thus,
he results from the CAT assays were consistent with the
esults from the gel shift assays (Fig. 2).
Our previous studies have shown that the IE protein
inds strongly to the IE promoter at the sequence from
11 to 114 relative to the transcription initiation site
11), which contains the highly conserved pentanucle-
tide 59-ATCGT-39 and binds weakly to sequences in the
and L promoters, which contain a degenerate version
f the consensus binding sequence 59-ATCGT-39 (13).
he IE protein bound weakly to the gK promoter DNA
hich also contains a degenerate version of the consen-
us binding sequence 59-ATCGT-39 (Fig. 2). The ICP4
rotein of HSV-1 represses transcription by binding to
NA in a precise way so that it may interact with the
asal transcription complex and inhibit a general step
nvolved in the function of activators (10). Repression of
ctivator function required that an ICP4 DNA binding site
as present in one orientation within approximately 45
p 39 to the TATA box (10). In the case of the EHV-1 IE and
ntanucleotide 59-ATCGT-39 or a mutant form of it. Top sequence shows
K promoter. Two possible IE protein binding sites (IEBS) and the TATA
he consensus pentanucleotide 59-ATCGT-39 are described on the left.
ed in triplicate. Data are averages, and standard deviations are shown.nsus pe
of the g
ant or tK genes, the IE protein binding site was present within
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177RAPID COMMUNICATION8 and 19 bp 39 to the TATA box, respectively (13, 23).
hese results suggest that the IE protein binds to the
ranscription initiation site of the gK promoter se-
uences, thereby repressing transcription.
The EICP0 Protein Increases the CAT Activity of the gK
romoter trans-Repressed by the IE Protein. As shown
bove, the IE protein trans-repressed the gK promoter. On
he other hand, the EICP0 protein activated expression of
he gK promoter (2). To determine how the IE and EICP0
roteins function together to regulate expression of the gK
romoter, additional transient-transfection assays were
erformed. A 6-fold increase in CAT activity was observed
hen the pgK-CAT reporter plasmid was cotransfected with
SVICP0K, which expresses the EICP0 protein (Fig. 4A, bar
). Consistent with the data presented above, the IE protein
ecreased the CAT activity controlled by the gK promoter
Fig. 4A, bar 3). When the pgK-CAT reporter plasmid was
otransfected with the pSVIE and pSVICP0K vectors, a
0-fold increase in CAT activity was observed (Fig. 4A, bar
) compared to those of the pSVIE vector only (Fig. 4A, bar
). However, the mutant IE protein (IEK498E) did not affect
he CAT activity of the gK promoter (Fig. 4A, bars 5 and 6).
hese results indicated that the EICP0 protein increased
he CAT activity of the gK promoter down-regulated by the
FIG. 4. Effect of the IE and EICP0 proteins on the gK promoter. (A) T
mol of pgK-CAT reporter plasmid and 0.3 pmol of effector plasmid.
rans-repressed by the IE protein. Two pmol of pgK-CAT chimeric plasm
nto L-M cells. The liposome-mediated DNA transfection and CAT assa
UC19 vector DNA. Each transfection was performed in triplicate. Da
escribed previously (2).E protein. tWhen a fixed amount of the pSVIE vector was cotrans-
ected with increasing amounts of the pSVICP0K vector,
he CAT activity of the gK promoter also increased in a
ose-dependent manner with regard to pSVICP0K (Fig.
B). When 0.1 pmol of pSVIE vector was cotransfected
ith 0.1 pmol of the pSVICP0K vector, the CAT activity of
he gK promoter increased by fivefold (FIg. 4B, bar 3).
hen 0.3 pmol of pSVIE vector was cotransfected with
.6 pmol of the pSVICP0K vector, CAT activity was in-
reased by twofold (Fig. 4B, bar 8). These results indi-
ated that transactivation of the gK promoter by the
ICP0 protein depends on the concentration of the IE
rotein. When the concentration of the pSVIE vector is
igh, the gK promoter cannot be transactivated efficiently
y high concentrations of the pSVICP0K vector.
To further investigate how the concentrations of the IE
nd EICP0 proteins affect the gK promoter, decreasing
oncentrations of pSVIE vector were cotransfected with
ncreasing concentrations of the pSVICP0K vector. When
he pgK-CAT reporter plasmid was cotransfected with 0.6
mol of the pSVIE vector alone, a 7-fold decrease in CAT
ctivity was observed (Fig. 4C, bar 2). Cotransfection of
.5 pmol pSVIE and 0.1 pmol pSVICP0K resulted in a
0-fold increase in CAT activity (Fig. 4C, bar 3) compared
rotein inhibit EICP0’s CAT activity. L-M cells were transfected with 2.0
C) The EICP0 protein increased the CAT activity of the gK promoter
cotransfected with different concentrations (pmol) of effector plasmids
re performed as described in Fig. 1. Controls were cotransfected with
averages; error bars show standard deviations. pSVICP0K has beenhe IE p
(B and
id was
ys we
ta areo those of the pSVIE vector only (Fig. 4C, bar 2). There-
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178 RAPID COMMUNICATIONfter, expression of pgK-CAT responded to cotransfection
ith pSVICP0K in a dose-dependent fashion (Fig. 4C,
ars 4 to 7). These results indicated that the EICP0
rotein is able to release the gK promoter from the
epression mediated by the IE protein. To exclude an-
ther possibility that the EICP0 protein inhibits expres-
ion of the IE protein, Western blot analyses were per-
ormed with anti-IE MAb. Even the highest concentration
f EICP0 did not inhibit IE protein synthesis (data not
hown).
It has been shown that the EICP0 and EICP22 pro-
eins function synergistically to trans-activate a g2 late
romoter (Bowles, D. E., and O’Callaghan, D. J., unpub-
ished observations). These results suggest that in the
E stage of infection, the IE protein turns off the ex-
ression of the true late gK gene. Thereafter, the early
egulatory proteins, such as EICP0 and EICP22, turn
n the expression of the gK gene (2). Expression of
HV-1 genes are coordinately expressed and tempo-
ally regulated in IE, E, and L fashions (3, 8). The EICP0
rotein is the only regulatory protein capable of inde-
endently activating g2 gene expression (2). Taken
ogether, these observations suggest that the EICP0
rotein plays a role as a regulatory factor that contrib-
tes to the switch from E to g1 and g2 late gene
xpression. Figure 3 showed that the EICP0 protein
ctivated the gK-CAT promoter to nearly the same
xtent regardless of the sequences at the IE binding
ites. This might suggest that in EHV-1 some late
enes require the EICP0 protein rather than the major
E regulator. Recently, we have employed an IE dele-
ion mutant virus and cell lines that constitutively ex-
ress the IE protein (7) as key reagents to develop a
anel of EHV-1 that harbor mutations of various types
n the IE gene. In the case of the IE mutant viruses that
ail to replicate in noncomplementing cells, it will be of
nterest to ascertain the molecular phenotype of these
utants. Specifically, the failure of any mutant virus to
eplicate due to a block in late gene expression either
ecause the EICP0 protein is not expressed or be-
ause late gene expression is repressed by the mu-
ant IE protein.
We realize the limitations of using transient transfec-
ion assays to elucidate the roles of viral regulatory
roteins during infection. As equine herpesviruses that
arbor specific mutations within the key regulatory
enes are generated, it may be possible to discover the
ultiple functions of these regulatory proteins in the
ontext of the virus and the infected cell. Indeed, this
pproach is the focus of our ongoing studies.
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